Galectin-3 and Oncofetal-Fibronectin Expression in Thyroid Neoplasia as Assessed by Reverse Transcription-Polymerase Chain Reaction and Immunochemistry in Cytologic and Pathologic Specimens

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Thyroid

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/105072503768499662PMID 14558920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular detection of thyroid cancer: an update

  2004cited by this paper
• Electrical Impedance Scanning of Thyroid Nodules Before Thyroid Surgery: A Prospective Study

  2004cited by this paper
• Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis

  2004cited by this paper
• Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma.

  2002cited by this paper
• Diagnostic utility of galectin‐3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules

  2002cited by this paper
• Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions.

  2002cited by this paper
• Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions.

  2001cited by this paper
• Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma.

  2001cited by this paper
• The IGF system in thyroid cancer: new concepts

  2001cited by this paper
• Difference in Patterns of Met Expression in Papillary Thyroid Carcinomas and Nonneoplastic Thyroid Tissue

  2001cited by this paper
• Preoperative diagnosis of thyroid carcinomas by aspiration biopsy-reverse transcription-polymerase chain reaction (ABRP): a report of two cases.

  2000cited by this paper
• Improving accuracy of cytology for nodular thyroid lesions.

  2000cited by this paper
• Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.

  2000cited by this paper
• Galectin‐3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression

  2000cited by this paper
• Involvement of galectin-3 expression in colorectal cancer progression and metastasis.

  1999cited by this paper
• Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.

  1999cited by this paper
• Expression of galectin‐3 in fine‐needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms

  1999cited by this paper
• Measurement of the Expression of Oncofetal Fibronectin mRNA in Thyroid Carcinomas by Competitive Reverse Transcription-Polymerase Chain Reaction

  1999cited by this paper
• Expression of c‐erbB‐2 oncoprotein in human thyroid tumours

  1999cited by this paper
• Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.

  1999cited by this paper
• Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.

  1999cited by this paper
• Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies.

  1998cited by this paper
• Galectin-3 is a presurgical marker of human thyroid carcinoma.

  1998cited by this paper
• Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study.

  1998cited by this paper
• Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma

  1998cited by this paper
• Fine-Needle Aspiration of Thyroid: An Institutional Experience

  1998cited by this paper
• Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.

  1998cited by this paper
• GALECTIN‐3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON‐NEOPLASTIC THYROID TISSUE

  1997cited by this paper
• Fine‐needle aspiration of thyroid nodules

  1997cited by this paper
• Immunohistochemical localization of p53 in human thyroid neoplasms: Correlation with biological behavior

  1997cited by this paper
• Expression of the endogenous galactose‐binding protein galectin‐3 correlates with the malignant potential of tumors in the central nervous system

  1997cited by this paper
• Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.

  1997cited by this paper
• Increased Expression of CD44 Variants in Differentiated Thyroid Cancers

  1996cited by this paper
• EGF‐receptors in human normal and pathological thyroid tissue

  1996cited by this paper
• Expression of a 31‐kDa lactoside‐binding lectin in normal human gastric Mucosa and in primary and metastatic gastric carcinomas

  1994cited by this paper
• Galectins. Structure and function of a large family of animal lectins.

  1994cited by this paper
• Diagnostic pitfalls in thyroid fine‐needle aspiration: A review of 394 cases

  1993cited by this paper
• A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

  1989cited by this paper
• Fine-needle aspiration and needle biopsy of the thyroid gland.

  1989cited by this paper
• Sources of diagnostic error in fine needle aspiration of the thyroid

  1989cited by this paper
• Structure and biology of proteoglycans.

  1988cited by this paper
• The role of fine‐needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm

  1986cited by this paper

• Research Progress on Tumor Molecular Markers of Papillary Thyroid Carcinoma

  2024cites this paper
• Shielding and nurturing: Fibronectin as a modulator of cancer drug resistance

  2023cites this paper
• Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells

  2020cites this paper
• Extradomain-B Fibronectin is a molecular marker of invasive breast cancer cells

  2019cites this paper
• BRAF mutation analysis by ARMS‐PCR refines thyroid nodule management

  2019cites this paper
• Molecular testing in the diagnosis of differentiated thyroid carcinomas.

  2018cites this paper
• Interstitial fibrosis in papillary thyroid microcarcinoma and its association with biological behavior

  2018cites this paper
• Galectin-3 Performance in Histologic and Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis

  2017cites this paper
• Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1

  2017cites this paper
• Chapter 92 – Thyroid Neoplasia

  2016cites this paper
• Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis

  2016cites this paper
• Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules

  2015cites this paper
• Application of immunohistochemistry in thyroid pathology.

  2015cites this paper
• Expression of ECM1 and MMP-2 in follicular thyroid lesions among Egyptians

  2015cites this paper
• Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature

  2015cites this paper
• Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing

  2015cites this paper
• Biomarkers in Myelodysplastic Syndrome

  2014cites this paper
• An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma

  2014cites this paper
• Molecular characterization of 54 cases of false‐negative fine‐needle aspiration among 1347 papillary thyroid carcinomas

  2014cites this paper
• Highlighting nuclear membrane staining in thyroid neoplasms with emerin: Review and diagnostic utility

  2013cites this paper
• Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis

  2012cites this paper
• Galectin-3 and CD44v6 as Markers for Preoperative Diagnosis of Thyroid Cancer by RT-PCR

  2011cites this paper
• The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas.

  2011cites this paper
• CXC Chemokine Receptor 4 Immunodetection in the Follicular Variant of Papillary Thyroid Carcinoma: Comparison to Galectin-3 and Hector Battifora Mesothelial Cell-1

  2010cites this paper
• Thyroid nodules; interpretation and importance of fine-needle aspiration (FNA) for the clinician - practical considerations.

  2010cites this paper
• Clinical implications of molecular studies for the diagnosis of thyroid cancer

  2010cites this paper
• Oncofetal Fibronectin mRNA Is Highly Abundant in the Blood of Patients with Papillary Thyroid Carcinoma and Correlates with High-Serum Thyroid-Stimulating Hormone Levels

  2010cites this paper
• Diagnostic utility of galectin-3 in thyroid cancer.

  2010cites this paper
• Molecular markers in thyroid cancer diagnostics.

  2009cites this paper
• Utilidad de la expresión de galectina-3 en el comportamiento clínico del cáncer diferenciado de tiroides

  2008cites this paper
• Thyroid fine‐needle aspiration samples inadequate for reverse transcriptase‐polymerase chain reaction analysis

  2008cites this paper
• [Usefulness of galectin-3 expression in the clinical behavior of differentiated thyroid carcinoma].

  2008cites this paper
• Perspectives for improved and more accurate classification of thyroid epithelial tumors.

  2008cites this paper
• Cytological and histological diagnoses of recurrent thyroid carcinoma with monoclonal antibody JT-95, which can detect modified fibronectin.

  2007cites this paper
• Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivity.

  2007cites this paper
• Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors.

  2007cites this paper
• Fine-Needle Aspiration Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma Through BRAFV600E Mutation and RET/PTC Rearrangement

  2007cites this paper
• [Expression of the selected adhesive molecules (cadherin E, CD44, LGAL3 and CA50) in papillary thyroid carcinoma].

  2006cites this paper
• Galectin‐3 is not useful in thyroid FNA

  2005cites this paper
• Usefulness of HBME‐1, cytokeratin 19 and galectin‐3 immunostaining in the diagnosis of thyroid malignancy

  2005cites this paper
• Galectin‐3 expression in papillary microcarcinoma of the thyroid

  2005cites this paper
• Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia

  2005cites this paper
• Molecular classification and biomarker discovery in papillary thyroid carcinoma

  2005cites this paper
• Galectin‐3 expression in papillary thyroid carcinoma: Relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size

  2005cites this paper
• Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.

  2005cites this paper
• Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma

  2005cites this paper
• Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.

  2004cites this paper
• Molecular detection of thyroid cancer: an update

  2004cites this paper
• Electrical Impedance Scanning of Thyroid Nodules Before Thyroid Surgery: A Prospective Study

  2004cites this paper